MedPath

Does Dexmedetomidine[a sleep inducing drug] prevent injection pain due to Propofol [an anaesthetic drug]?- a study

Phase 3
Recruiting
Conditions
Patients coming for surgery under general anaesthesia
Registration Number
CTRI/2012/01/002364
Lead Sponsor
S N Medical college
Brief Summary

It is well known fact that propofol causes pain when injected intravenously. Several agents are used to reduce this pain. This prospective, double blind, placebo controlled trail is designed to determine the efficacy of Dexmedetomidine in reducing the propofol injection pain.

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
All
Target Recruitment
100
Inclusion Criteria

ASA I and II patients undergoing general anaesthesia.

Exclusion Criteria

paediatric patients ASA III and IV patients patients allergic to Dexmedetimidine Neuropsychiatric patients.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
proportion of patients attaining pain relief for injection pain due to propofol5min
Secondary Outcome Measures
NameTimeMethod
proportion of patients showing reduced withdrawal movements to propofol injection5min

Trial Locations

Locations (1)

Department of Anaesthesiology

🇮🇳

Bagalkot, KARNATAKA, India

Department of Anaesthesiology
🇮🇳Bagalkot, KARNATAKA, India
Dr Uday Ambi
Principal investigator
9880570780
udayambi@ymail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.